v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Cash flows from operating activities          
Net income (loss) $ 99,795 $ 26,944 $ 157,980 $ 151,492  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Provision for loss on receivables and retained interests in securitization trusts     4,850 (2,177)  
Depreciation and amortization     418 515  
Amortization of financing costs     7,895 8,192  
Equity-based expenses     18,272 17,341  
Equity method investments     (171,121) (161,958)  
Non-cash gain on securitization     (11,407) (53,891)  
(Gain) loss on sale of receivables and debt securities     0 8,532  
Loss on debt extinguishment     10,557 0  
Changes in receivables held-for-sale     (4,285) (6,750)  
Changes in accounts payable and accrued expenses     30,545 50,801  
Change in accrued interest on receivables and debt securities     (27,371) (33,242)  
Cash received (paid) upon hedge settlement     17,696 19,261  
Other     8,421 (2,002)  
Net cash provided by (used in) operating activities     42,450 (3,886)  
Cash flows from investing activities          
Equity method investments     (299,980) (168,896)  
Equity method investment distributions received     19,529 11,426  
Proceeds from sales of equity method investments     0 2,107  
Purchases of and investments in receivables     (287,049) (347,343)  
Principal collections from receivables     172,080 470,788  
Proceeds from sales of receivables     8,344 99,166  
Proceeds from sale of real estate     0 115,767  
Purchases of debt securities and retained interests in securitization trusts     (6,545) 0  
Collateral provided to hedge counterparties     (4,110) (1,140)  
Collateral received from hedge counterparties     5,340 4,010  
Other     8,230 (680)  
Net cash provided by (used in) investing activities     (384,161) 185,205  
Cash flows from financing activities          
Proceeds from credit facilities     395,000 616,792  
Principal payments on credit facilities     (395,000) (701,792)  
Proceeds from issuance of term loan     0 250,000  
Principal payments on term loan     (11,124) (561,023)  
Proceeds from (repayments of) commercial paper notes     256,500 80,000  
Proceeds from issuance of senior unsecured notes     996,174 205,500  
Principal payments on convertible notes     (200,000) 0  
Redemption of senior unsecured notes     (700,000) 0  
Net proceeds of common stock issuances     119,876 82,014  
Payments of dividends and distributions     (102,443) (93,280)  
Redemption premium paid     (6,645) 0  
Payment of financing costs     (7,195) (19,711)  
Collateral provided to hedge counterparties     (110,320) (90,860)  
Collateral received from hedge counterparties     71,890 114,700  
Other     (6,402) (1,435)  
Net cash provided by (used in) financing activities     295,361 (95,053)  
Increase (decrease) in cash, cash equivalents, and restricted cash     (46,350) 86,266  
Cash, cash equivalents, and restricted cash at beginning of period     150,156 75,082 $ 75,082
Cash, cash equivalents, and restricted cash at end of period $ 103,806 $ 161,348 103,806 161,348 $ 150,156
Interest paid     146,497 110,097  
Supplemental disclosure of non-cash activity          
Interests retained from securitization transactions     18,662 28,164  
Equity method investments retained from securitization and deconsolidation transactions     0 32,564  
Equity method investments retained from sale of assets upon establishment of co-investment structure     0 54,655  
Deconsolidation of non-recourse debt     0 51,233  
Deconsolidation of assets pledged for non-recourse debt     0 51,761  
Removal of deferred financing obligation upon securitization     29,051 0  
Non-recourse debt          
Cash flows from financing activities          
Proceeds from issuance of non-recourse debt     0 94,000  
Principal payments on non-recourse debt     $ (4,950) $ (69,958)